MOLNUPIRAVIR's Background
Molnupuravir (200 mg) is an antiviral agent that has been approved for the mild-to-moderate treatment of COVID-19. Coronavirus disease (Covid-19), also known as SARS-CoV-2 (Severe Acute Respiratory Syndrome Corona Virus 2), is a coronavirus-caused infectious disease. Its symptoms include fever and cough, which can progress to pneumonia and respiratory failure in some...
0 Commentarios
0 Acciones
764 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
